Advanced search
Publication Cover
Pediatric Rehabilitation Volume 5, 2002 - Issue 3
Journal homepage
32
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Aerobic capacity in late adolescents infected with HIV and controls

W. Todd Cade University of Maryland School of Medicine, 100 Penn Street AHB 115, Baltimore, MD 21201-1082, USA.
,
Ligia Peralta University of Maryland School of Medicine, 100 Penn Street AHB 115, Baltimore, MD 21201-1082, USA.
&
Randall E. Keyser University of Maryland School of Medicine, 100 Penn Street AHB 115, Baltimore, MD 21201-1082, USA.
Pages 161-169 | Published online: 10 Jul 2009

  • JOHNSON, J. E., ANDERS, G. T., BLANTON, H. M., et al.: Exercise dysfunction in patients seropositive for the human immunodeficiency virus. American Review of Respiratory Disease, 141: 618622, 1990.
  • MACARTHUR, R. D., LEVINE, S. D. and BIRK, T. J.: Supervised exercise training improves cardiopulmonary fitness in HIVinfected persons. Medicine and Science in Sports and Exercise, 25: 684-688, 1993.
  • POTHOFFG., WASSERMANN K. and OSTMANN H.: impairment of exercise capacity in various groups of HIV-infected patients. Respiration, 61: 80-85, 1994.
  • STRINGER, W. W., BEREZOVSKAYA M., O'BRIEN, W. A., et al.: The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients. Medicine and Science in Sports and Exercise, 30: 11-16, 1998.
  • PERNA, F. M., LAPERRIERE, A., KLIMAS, N., et al.: Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Medicine and Science in Snorts and Exercise, 31: 973-979, 1999.
  • KEYSER,R. R, PERALTA, L., CADE, W. T.,et al.: Functional aerobic impairment in adolescents seropositive for HIV: a quasiexperimental analysis. Archives of Physical Medicine and Rehabilitation, 81: 1479-1484, 2000.
  • FRANXLIN, B. A. and TIMMIS, G. C.: Fundamentals of exercise physiology: implications for exercise testing and prescription. In: B. A. Franklin and G. C. Timmis (editors) Exercise in Modern Medicine. (Williams and Wilkins: Baltimore), p. 8, 1989.
  • YAMABE,H.,KOBAYASHI,K.,TAKATA,T.,et al.: Reduced chronotropic reserve to the metabolic requirement during exercise in advanced heart failure with old myocardial infarction. Japanese Circulation Journal. 51: 259-264, 1987.
  • BALOGUN, M. O., AJAYI, A. A. and LADIPO, G. O.: Spectrum of treadmill exercise responses in Africans with normotension, essential hypertension and hypertensive heart failure. International Journal of Cardiology, 21: 293-300, 1988.
  • DOBA, N., SHUKUYA, M., YOSHIDA, H., et al.: Physical training of the patients with coronary heart disease: noninvasive strategies for the evaluation of its effects on the oxygentransport system and myocardial ischemia. Japanese Circulation Journal, 54:1409-1418, 1990.
  • ZDRENGHEA, D. G. N., PREDESCU, D, TIMIS, D, et al.: Exercise testing in patients with valvular disease. Romanian Journal of Internal Medicine, 32: 23-28, 1994.
  • BUSSIERES, L. M., PFLUGFELDER, P. W., MENKIS, A. H., et al:Basis for aerobic impairment in patients after heart transplantation. Journal of Heart and Lung Transplantation, 14: 1073-1080, 1995.
  • LEGGET, M. E., KUUSISTQ, J., HEALY, N. L., et al.: Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis, American Heart Journal, 131: 94100, 1996.
  • STRINGER, W. W.: Mechanisms of exercise limitation in HIV+ individuals. Medicine and Science in Sports and Exercise, 32: 8412-S421, 2000.
  • HOPEWELL, P. C. and LUCE,J.M.: Pulmonary involvement in the acquired immunodeficiency syndrome. Chest, 87: 104-112, 1985.
  • STOVER, D. E., WHITE, D. A., ROMANO, P. A., et al: Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. American Journal of Medicine, 78: 429437, 1985.
  • RICHMAN, D. D., FISCHL, M. A., GRIECO, M. H., et al.: The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial, New England Journal of Medicine, 317: 192-197, 1987.
  • CALABRESE, L. H., PROFFITT, M. R., YEN-LIEBERMAN, B., et al.: Congestive cardiomyopathy and illness related to the acquired immunodeficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium. Annals of Internal Medicine, 107: 691-692, 1987.
  • GRODY, W. W., CHENG, L. and LEWIS, W.: infection of the heart by the human immunodeficiency virus. American Journal of Cardiology, 66: 203-206, 1990.
  • HECHT, S. R., BERGER, M., VAN TOSH, A., et al.: Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest, 96: 805-808, 1989.
  • GRAU, J. M., MASANES, F., PEDROL, E., et al.: Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy. Annals of Neurology, 34: 206-211, 1993.
  • LANE, R. J., MCLEAN, K. A., Moss, J., et al. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathology and Applied Neurobiology, 19: 406-413, 1993.
  • BENBRIK, E., CHARIOT, P., BONAVAUD, S., et al.: Cellular and mitochondria! toxicity of zidovudine (AZT), didanosine (ddl) and zalcitabine (ddC) on cultured human muscle cells. Journal of Neurological Sciences, 149: 19-25, 1997.
  • CHARIOT, P., BENBRIK, E., SCHAEFFER, A., et al.: Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine. Acta Neuropathology, 85: 431-436, 1993.
  • CENTERS FOR DISEASE CONTROL AND PREVENTION; Revised Surveillance Case Definition for HIV Infection. Morbidity and Mortality Weekly Report, 48(RR13): 29-31, 1999.
  • Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents by a Panel on Clinical Practices for Treatment of HIV Infection. HIV Clinical Trials, 2: 227-306, 2001.
  • AMERICAN COLLEGE OF SPORTSMEDICINE: ACSM's Guidelines for Exercise Testing and Prescription. (Williams and Wilkins: Baltimore), 1991.
  • WASSERMANN, K. H. J., SUE, D. Y. and WHIPP, B. J.: principles of Exercise Testing and Interpretation (Lea and Febiger: Philadelphia), 1994.
  • LEWIS, S. F. and HALLER, R. G.: Physiologic measurement of exercise and fatigue with special reference to chronic fatigue syndrome. Reviews of Infectious Diseases, 13: S98-S108, 1991.
  • PlNA, C. R.: Lead systems: sensitivity and specificity. Cardiology Clinics, 2: 329-335, 1984.
  • NEVILL, A. M. and HOLDER, R. L.: Body mass index: a measure of fatness or leanness? British Journal of Nutrition, 73: 507-517, 1995.
  • ROSENBERG, P. S., BIGGAR, R. J. and GOEDERT, J. J.: Declining age at HIV infection in the United States. New England Journal of Medicine, 330: 789-790, 1994.
  • NEUFER, P. D., COSHLL, D. L., FLYNN, M. G., et al.: Improvements in exercise performance: effects of carbohydrate feedings and diet. Journal of Applied Physiology, 61: 983-988, 1987.
  • POOLE, D. C. and RICHARDSON, R. S.: Determinants of oxygen uptake. Implications for exercise testing. Sports Medicine, 24: 308-320, 1997.
  • VAN DER BEEK, E. J., VAN DOKKUM, W., WEDEL, M., et al.: Thiamin, riboflavin and vitamin B6: impact of restricted intake on physical performance in man. Journal of the American College of Nutrition, 13: 629-640, 1994.
  • KAUL, S., FISHBEIN, M. C. and SIEGEL, R. J.: Cardiac manifestations of acquired immune deficiency syndrome: a 1991 update. American Heart Journal, 122: 535-544, 1991.
  • LEWIS, W., PAPOIAN, T., GONZALEZ, B., et al.: Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Laboratory Investigation, 65: 228-236, 1991.
  • MILEI, J., GRANA, D., FERNANDEZ-ALONSO, G., et al.: Cardiac involvement in acquired immunodeficiency syndrome--a review to push action. The Committee for the Study of Cardiac Involvement in AIDS. Clinical Cardiology, 21: 465-472, 1998.
  • RERKPATTANAPIPAT, P. and WONGPRAPARUT, N., JACOBS, L. E., et al.: Cardiac manifestations of acquired immunodeficiency syndrome. Archives of Internal Medicine, 160: 602-608, 2000.
  • YUNIS, N. A. and STONE, V. E.: Cardiac manifestations of HIV/ AIDS: a review of disease spectrum and clinical management. Journal of the Acquired Immune Deficiency Syndrome and Human Retrovirology, 18: 145-154, 1998.
  • DOMANSKI, M. J., SLOAS, M. M., FOLLMANN, D. A., et al.: Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. Journal of Pediatrics, 127: 137-146, 1995.
  • MORGELLO, S., WOLFE, D., GODFREY, E., et al.: Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathology, 90: 366-74, 1995.
  • DALAKAS, M. C., PEZESHKPOUR, G. H., GRAVELL, M., et al.: Polymyositis associated with AIDS retrovirus. Journal of the American Medical Association, 256: 2381-2383, 1986.
  • CHAD, D. A., SMITH, T. W., BLUMENFELD, A., et al.: Human immunodeficiency virus (HlV)-associated myopathy: immunocytochemical identification of an HIV antigen (gp 41) in muscle macrophages. Annals of Neurology, 28: 579-582, 1990.
  • GHERARDI, R. K., FLOREA-STRAT, A., FROMONT, G., et al: Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers. Annals Neurology, 36: 752-758, 1994.
  • SIMPSON, D. M., CITAK, K. A., GODFREY, E., et al.: Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology, 43: 971-976, 1993.
  • CUPLER, E. J., LBON-MONZON, M., MILLER, J., et al.: inclusion body myositis in HIV-I and HTLV-I infected patients. Brain, 119: 1887-1893,1996.
  • CHARIOT, P., MONNET, I. and GHERARDI, R.: Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Annals of Neurology, 34: 561-565, 1993.
  • MCCURDY, D. T. 3RD. and KENNEDY, J. M.: AZT decreases rat myocardial cytochrome oxidase activity and increases beta-myosin heavy chain content. Journal of Molecular and Cellular Cardiology, 30: 1979-1989, 1998.
  • DE LA ASUNOON, J. G., DEL OLMO, M. L., SASTRE, J., et al.:Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver. Hepatology, 29: 985-987, 1999.
  • SZABADOS, E., FISCHER, G. M., TOTH, K., et al.: Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radicals in Biology and Medicine, 26: 309-317, 1999.
  • LEWIS, W., GONZALEZ, B., CHOMYN, A. and PAPOIAN, T.: Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. Journal of Clinical Investigation,89: 1354-1360, 1992.
  • ARNAUDO, E., DALAKAS, M., SHANSKE, S., et al.: Depletion of muscle mitochondrial DNA in AIDS patients with zidovudineinduced myopathy. Lancet, 337: 508-510, 1991.
  • GONZALEZ, CID. M. and LARRIPA, I. Genotoxic activity of azidothymidine (AZT) in in vitro systems. Mutation Research, 321: 113-118,1994.
  • WEISSMAN, J. D., CONSTANTINITIS, I., HUDGINS, P., et al.: 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients. Neurology, 42: 619-623, 1992.
  • SINNWELL T. M., SIVAKUMAR K., SOUEIDAN S., et al: Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy. Journal of Clinical Investigation, 96: 126-131, 1995.
  • RUTENFRANZ, J., LANGE ANDERSEN, K., SELIGER, V., et al.: Maximal aerobic power affected by maturation and body growth during childhood and adolescence. European Journal of Pediatrics, 139: 106-112,1982.
  • BEUNEN, G., BAXTER-JONES, A. D., MIRWALD, R. L., et al.: Intraindividual allometric development of aerobic power in 8- to 16- year-old boys. Medicine and Science in Sports and Exercise, 34: 503-510, 2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.